128 related articles for article (PubMed ID: 38332401)
21. Association Between Vaso-Occlusive Crises and Opioid Prescriptions Among Patients with Sickle Cell Disease: A Retrospective Claims-Based Study.
Kang HA; Barner JC; Richards KM; Bhor M; Paulose J; Kutlar A
J Health Econ Outcomes Res; 2020; 7(1):94-101. PubMed ID: 36873574
[No Abstract] [Full Text] [Related]
22. Association between Vaso-occlusive Crises and Opioid Prescriptions among Patients with Sickle Cell Disease: A Retrospective Claims-based Study.
Kang HA; Barner JC; Richards KM; Bhor M; Paulose J; Kutlar A
J Health Econ Outcomes Res; 2020; 7(1):94-101. PubMed ID: 32685602
[TBL] [Abstract][Full Text] [Related]
23. Cytokine profile of sickle cell disease in Oman.
Pathare A; Al Kindi S; Alnaqdy AA; Daar S; Knox-Macaulay H; Dennison D
Am J Hematol; 2004 Dec; 77(4):323-8. PubMed ID: 15551290
[TBL] [Abstract][Full Text] [Related]
24. Heart rate variability study in adult Nigerian subjects with sickle cell disease during vaso-occlusive crisis.
Adebiyi AA; Oyebowale OM; Olaniyi AJ; Falase AO
Niger Postgrad Med J; 2019; 26(1):8-12. PubMed ID: 30860193
[TBL] [Abstract][Full Text] [Related]
25. Conjunctival microvascular hemodynamics following vaso-occlusive crisis in sickle cell disease.
Kord Valeshabad A; Wanek J; Gaynes B; Saraf SL; Molokie R; Shahidi M
Clin Hemorheol Microcirc; 2015 Sep; 62(4):359-67. PubMed ID: 26444608
[TBL] [Abstract][Full Text] [Related]
26. Pattern of serum cytokine expression and T-cell subsets in sickle cell disease patients in vaso-occlusive crisis.
Musa BO; Onyemelukwe GC; Hambolu JO; Mamman AI; Isa AH
Clin Vaccine Immunol; 2010 Apr; 17(4):602-8. PubMed ID: 20130127
[TBL] [Abstract][Full Text] [Related]
27. Liver stiffness increases acutely during sickle cell vaso-occlusive crisis.
Koh C; Turner T; Zhao X; Minniti CP; Feld JJ; Simpson J; Demino M; Conrey AK; Jackson MJ; Seamon C; Kleiner DE; Kato GJ; Heller T
Am J Hematol; 2013 Nov; 88(11):E250-4. PubMed ID: 23828202
[TBL] [Abstract][Full Text] [Related]
28. High lactate dehydrogenase levels at admission for painful vaso-occlusive crisis is associated with severe outcome in adult SCD patients.
Stankovic Stojanovic K; Steichen O; Lefevre G; Bachmeyer C; Avellino V; Grateau G; Girot R; Lionnet F
Clin Biochem; 2012 Dec; 45(18):1578-82. PubMed ID: 22892192
[TBL] [Abstract][Full Text] [Related]
29. Shear-Stress-Gradient and Oxygen-Gradient Ektacytometry in Sickle Cell Patients at Steady State and during Vaso-Occlusive Crises.
Boisson C; Nader E; Renoux C; Gauthier A; Poutrel S; Bertrand Y; Stauffer E; Virot E; Hot A; Fort R; Cannas G; Joly P; Connes P
Cells; 2022 Feb; 11(3):. PubMed ID: 35159394
[TBL] [Abstract][Full Text] [Related]
30. GlycA is not a useful biomarker of inflammation in sickle cell disease.
Weisman JK; Meeks D; Mendelsohn L; Remaley AT; Sampson M; Allen DT; Nichols J; Shet AS; Thein SL
Int J Lab Hematol; 2018 Dec; 40(6):704-709. PubMed ID: 30152174
[TBL] [Abstract][Full Text] [Related]
31. Plasma L-Arginine in Sickle Cell Anaemia Patients in Crises and its Correlation with Markers of Severity of Disease.
Aworanti OW; Akingbola TS; Adeomi A; Alagbe AE; Salako AO
West Afr J Med; 2021 Apr; 38(4):366-373. PubMed ID: 33902958
[TBL] [Abstract][Full Text] [Related]
32. Pro-inflammatory cytokines associate with NETosis during sickle cell vaso-occlusive crises.
Barbu EA; Mendelsohn L; Samsel L; Thein SL
Cytokine; 2020 Mar; 127():154933. PubMed ID: 31778959
[TBL] [Abstract][Full Text] [Related]
33. Investigation of thrombin generation assay to predict vaso-occlusive crisis in adulthood with sickle cell disease.
Feugray G; Kasonga F; Grall M; Dumesnil C; Benhamou Y; Brunel V; Le Cam Duchez V; Lahary A; Billoir P
Front Cardiovasc Med; 2022; 9():883812. PubMed ID: 36277754
[TBL] [Abstract][Full Text] [Related]
34. Serum IL-6, IL-10, and TNFα levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition.
Sarray S; Saleh LR; Lisa Saldanha F; Al-Habboubi HH; Mahdi N; Almawi WY
Cytokine; 2015 Mar; 72(1):43-7. PubMed ID: 25569375
[TBL] [Abstract][Full Text] [Related]
35. Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients.
Bartolucci P; Habibi A; Khellaf M; Roudot-Thoraval F; Melica G; Lascaux AS; Moutereau S; Loric S; Wagner-Ballon O; Berkenou J; Santin A; Michel M; Renaud B; Lévy Y; Galactéros F; Godeau B
EBioMedicine; 2016 Aug; 10():305-11. PubMed ID: 27412264
[TBL] [Abstract][Full Text] [Related]
36. Increased Vasoocclusive Crises in "O" Blood Group Sickle Cell Disease Patients: Association with Underlying Thrombospondin Levels.
Al Huneini M; Alkindi S; Panjwani V; Al Falahi K; Al Balushi B; Gravell D; Ho CH; Krishnamoorthy R; Pathare AV
Mediterr J Hematol Infect Dis; 2017; 9(1):e2017028. PubMed ID: 28512557
[TBL] [Abstract][Full Text] [Related]
37. Sickle cell vaso-occlusive crisis is associated with abnormalities in the ratio of vasoconstrictor to vasodilator prostanoids.
Setty BN; Chen D; Stuart MJ
Pediatr Res; 1995 Jul; 38(1):95-102. PubMed ID: 7478805
[TBL] [Abstract][Full Text] [Related]
38. Real-World data on efficacy of L-glutamine in preventing sickle cell disease-related complications in pediatric and adult patients.
Elenga N; Loko G; Etienne-Julan M; Al-Okka R; Adel AM; Yassin MA
Front Med (Lausanne); 2022; 9():931925. PubMed ID: 35979207
[TBL] [Abstract][Full Text] [Related]
39. Defective lipid metabolism in sickle cell anaemia subjects in vaso-occlusive crisis.
Akinlade KS; Adewale CO; Rahamon SK; Fasola FA; Olaniyi JA; Atere AD
Niger Med J; 2014 Sep; 55(5):428-31. PubMed ID: 25298610
[TBL] [Abstract][Full Text] [Related]
40. Levels of Soluble Endothelium Adhesion Molecules and Complications among Sickle Cell Disease Patients in Ghana.
Antwi-Boasiako C; Donkor ES; Sey F; Dzudzor B; Dankwah GB; Otu KH; Doku A; Dale CA; Ekem I
Diseases; 2018 Apr; 6(2):. PubMed ID: 29690499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
